Across these studies, safety was consistently excellent, with almost no negative effects reported (Ebadi et al., 2023)
These findings are based on laboratory research, making FOXO4-DRI valuable for scientists exploring senolytic mechanisms
Phase 1 is the in office intensive depigmentation peel which is performed by Dr
NAP and its metabolites are found to have LUMO-HOMO energy differences ranging from 4.4 to 4.5 eV from DFT calculations, indicating that in terms of kinetic lability they would be similar (neither highly inert nor exceedingly labile)
Swapping in the triple agonist is the upgrade path, with the trade-off being that the specific pairing has not been formally trialed
Get in touch today to book your consultation and take the initial step towards a brighter, more even complexion